People: Mylan Inc. (MYL.O)

MYL.O on Nasdaq

17.68USD
9 Feb 2010
Price Change (% chg)

$-0.08 (-0.45%)
Prev Close
$17.68
Open
--
Day's High
$17.96
Day's Low
$17.54
Volume
5,953,376
Avg. Vol
6,529,528
52-wk High
$19.21
52-wk Low
$11.14

view people for:

Summary

Name Age Since Current Position
Coury, Robert 48 2009 Chairman of the Board, Chief Executive Officer
Bresch, Heather 39 2009 President
Piatt, Rodney 56 2009 Vice Chairman of the Board
Barret, Didier 44 2009 President - European Generic Medicines Association
Malik, Rajiv 2009 Chief Operating Officer
Rizzo, Daniel 46 2007 Senior Vice President, Corporate Controller
Todd, C. 75 2002 Director
Leech, Douglas 55 2000 Director
Vanderveen, Randall 58 2002 Director
Cameron, Wendy 49 2002 Director
Maroon, Joseph 68 2003 Director
Dimick, Neil 60 2005 Director
Parrish, Mark 53 2009 Director
» Insider Trading

Biographies

Name Description
Coury, Robert Mr. Robert J. Coury has been Chairman of the Board, Chief Executive Officer of Mylan Inc. He has served as Vice Chairman of the Board of Mylan Inc. since March 2002 and Chief Executive Officer of Mylan (since September 2002); founder, Chief Executive Officer and principal owner of Coury Consulting, L.P., a Pittsburgh, Pennsylvania corporate advisory firm (1989-2002); Non-Executive Chairman of the Board of Matrix Laboratories Limited (“Matrix”), a majority-owned subsidiary of Mylan.
Bresch, Heather Ms. Heather Bresch has been appointed as President of Mylan Inc effective July 29, 2009. She has served as Mylan Inc.s' Executive Vice President and Chief Operating Officer since October 2007, before which she was Head of North American Operations since January 2007. She previously served as Senior Vice President, Strategic Corporate Development, beginning in February 2006. Ms. Bresch joined Mylan in 1992, and has held a number of management positions, including Vice President, Strategic Corporate Development from May 2005 to February 2006, Vice President of Public and Government Relations from February 2004 to April 2005, Director of Government Relations from March 2002 to February 2004, and Director of Business Development from January 2001 to March 2002.
Piatt, Rodney Mr. Rodney L. Piatt, C.P.A. has been Vice Chairman of the Board of Mylan Inc. He has served as Director of Mylan Inc. since 2004. He is President and owner of Horizon Properties, a real estate and development company (1996-present); Chief Executive Officer and Director of Lincoln Manufacturing Inc., a steel and coal manufacturing company (2003-present).
Barret, Didier Mr. Didier Barret has been appointed as President - European Generic Medicines Association of Mylan Inc. Mr. Didier Barret had served as President, Europe, Middle East and Africa since October 2007, prior to which he served as the Regional Director of Merck Generics from 2004 to 2007 (which at the time was owned by Merck KGaA). From 2000 to 2004, Mr. Barret was the Area Director for Merck Generics in France, Belgium, Italy, Spain and Portugal.
Malik, Rajiv Mr. Rajiv Malik has been appointed as Chief Operating Officer of Mylan Inc effective July 29, 2009. He has served as Mylan Inc.'s Head of Global Technical Operations since January 2007, as Executive Vice President since October 2007. Previously, he served as Chief Executive Officer of Matrix from July 2005 to June 2008. Prior to joining Matrix, he served as Head of Global Development and Registrations for Sandoz GmbH from September 2003 to July 2005. Prior to joining Sandoz, Mr. Malik was Head of Global Regulatory Affairs and Head of Pharma Research for Ranbaxy from October 1999 to September 2003.
Rizzo, Daniel Mr. Daniel C. Rizzo, Jr., C.P.A. has served as Mylan Inc.'s Corporate Controller since June 2006 and as Senior Vice President since October 2007. He joined the Company as Vice President and Corporate Controller in June 2006, prior to which he served as Vice President and General Controller of Hexion Specialty Chemicals, Inc. from October 2005 to May 2006, before which he served as Vice President and Corporate Controller at Gardner Denver, Inc. since 1998.
Todd, C. Mr. C. B. Todd has been a Director of Mylan Inc. since 1993. He is Retired; President and Chief Operating Officer of Mylan (2001-2002); positions with Mylan in various capacities from 1970 until his initial retirement in 1999, including Senior Vice President (1987-1999), President, Mylan Pharmaceuticals (1991-1999), Senior Vice President, Mylan Pharmaceuticals (1987-1991) and Vice President-Quality Control, Mylan Pharmaceuticals (1978-1987).
Leech, Douglas Mr. Douglas J. Leech, C.P.A. is a Director of Mylan Inc. since 2000. He is Chairman, President and Chief Executive Officer of Centra Bank, Inc. and Centra Financial Holdings, Inc. (since 1999); former Chief Executive Officer and President of Huntington Banks West Virginia.
Vanderveen, Randall Dr. Randall L. Vanderveen, Ph.D., is a Director of Mylan Inc. since 2002. He is Dean, John Stauffer Decanal Chair, School of Pharmacy, University of Southern California (since September 2005); Dean of the School of Pharmacy and Graduate School of Pharmaceutical Science and Professor of Pharmacy at Duquesne University, Pittsburgh, Pennsylvania (1998-2005); Assistant Dean and Associate Professor at Oregon State University, Portland, Oregon (1988-1998).
Cameron, Wendy Ms. Wendy Cameron is a Director of Mylan Inc. since 2002. He is Director and Co-Owner of Cam Land LLC, a harness racing business in Washington, Pennsylvania (since January 2003); Vice President, Divisional Sales & Governmental Affairs, Cameron Coca-Cola Bottling Company, Inc. (1981-1998); Chairman of the Washington Hospital Board of Trustees and of the Washington Hospital Executive Committee.
Maroon, Joseph Dr. Joseph C. Maroon, M.D. is a Director of Mylan Inc. since 2003. He is Professor, Heindl Scholar in Neuroscience and Vice Chairman of the Department of Neurosurgery, University of Pittsburgh Medical Center (“UPMC”) and other positions at UPMC (since 1998).
Dimick, Neil Mr. Neil Dimick, C.P.A. is a Director of Mylan Inc. since 2005. He is Retired; Executive Vice President and Chief Financial Officer of Amerisource Bergen Corporation, a wholesale distributor of pharmaceuticals (2001-2002); Senior Executive Vice President and Chief Financial Officer of Bergen Brunswig Corporation, a wholesale drug distributor (1992-2001); Director of HLTh Corporation (formerly Emdeon Corporation), WebMD Health Corp., Alliance Imaging, Inc., Thoratec Corporation and Resources Connection, Inc.
Parrish, Mark Mr. Mark W. Parrish is a Director of Mylan Inc. Mr. Parrish has been chairman and CEO of Trident USA Health Services, provider of mobile X-ray and laboratory services to the long-term care industry. In addition to his current role at Trident, Parrish also is president of the International Federation of Pharmaceutical Wholesalers, an association comprised of the largest pharmaceutical wholesalers and pharmaceutical supply chain service companies in the world. He also serves as a senior adviser to Frazier Healthcare Ventures, a health care oriented growth equity firm, and as a director of Biovail Corporation. Previously, Parrish was CEO of Healthcare Supply Chain Services for Cardinal Health, manufacturer and distributor of medical and surgical supplies and technologies. Parrish also held a variety of other leadership roles at Cardinal Health including group president, Pharmaceutical Supply Chain Services; president and chief operating officer, Pharmaceutical Supply Chain Services; chairman and CEO, Pharmaceutical Distribution and Provider Services; executive vice president and group president, Pharmaceutical Distribution; and president, Medicine Shoppe.

Basic Compensation

Name Fiscal Year Total
Coury, Robert 12,475,100
Bresch, Heather 2,973,430
Piatt, Rodney --
Barret, Didier 2,153,830
Malik, Rajiv 2,872,970
Rizzo, Daniel --
Todd, C. 946,700
Leech, Douglas --
Vanderveen, Randall --
Cameron, Wendy --
Maroon, Joseph --
Dimick, Neil --
Parrish, Mark --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Coury, Robert 1,816,875 9,092,430
Bresch, Heather 0 0
Piatt, Rodney 0 0
Barret, Didier 0 0
Malik, Rajiv 0 0
Rizzo, Daniel 0 0
Todd, C. 360,000 4,250,830
Leech, Douglas 0 0
Vanderveen, Randall 0 0
Cameron, Wendy 0 0
Maroon, Joseph 0 0
Dimick, Neil 0 0
Parrish, Mark 0 0

Insider Trading

Name Shares Traded Price
MALIK RAJIV 10,000 $0.00
LEECH DOUGLAS J 13,352 $18.49
LEECH DOUGLAS J 3,423 $18.50
LEECH DOUGLAS J 8,438 $10.27
LEECH DOUGLAS J 100 $18.50
LEECH DOUGLAS J 16,875 $11.11
MALIK RAJIV 9,889 $0.00
COURY ROBERT J 18,135 $12.10
BRESCH HEATHER M 3,909 $12.10
BRESCH HEATHER M 9,889 $0.00
RIZZO DANIEL C JR 1,500 $0.00
COURY ROBERT J 45,886 $0.00
MAROON JOSEPH C 6,269 $0.00
LEECH DOUGLAS J 6,269 $0.00
PIATT RODNEY L 6,269 $0.00
DIMICK NEIL F 6,269 $0.00
VANDERVEEN RANDALL L 6,269 $0.00
PUSKAR MILAN 6,269 $0.00
TODD CLARENCE B 6,269 $0.00
NIMMAGADDA PRASAD 6,269 $0.00
CAMERON WENDY 6,269 $0.00
COURY ROBERT J 21,487 $0.00
COURY ROBERT J 8,827 $13.41
MALIK RAJIV 5,690 $13.20
BORKOWSKI EDWARD J 16,910 $0.00
» Full list on Insider Trading
view people for: